Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of PEG Bowel Preparation on Gut Microbiome
NCT06831539Phase 1Completed
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- Dec 2024
- Primary completion
- Jul 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of sodium sulfate, sponsored by Centre hospitalier de l’Université de Montréal. Primary endpoint: Percentage changes in Gut Metabolite Concentrations at 1 month. Started Dec 2024; status: completed.
02
Drugs
sodium sulfate
Beyond the preview
Go deeper on NCT06831539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06831539.